Search Results - "Heller, Keith S."

Refine Results
  1. 1

    Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma by Zagzag, Jonathan, MD, Pollack, Aron, MD, Dultz, Linda, MD, Dhar, Shumon, BS, Ogilvie, Jennifer B., MD, Heller, Keith S., MD, Deng, Fang-Ming, MD, Patel, Kepal N., MD

    Published in Surgery (01-12-2013)
    “…Background BRAF V600E mutation is the most common genetic alteration in papillary thyroid cancer (PTC). We used a mutation-specific antibody for…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Thyroid cancer is more likely to be detected incidentally on imaging in private hospital patients by Zagzag, Jonathan, MD, Kenigsberg, Alexander, Patel, Kepal N., MD, Heller, Keith S., MD, Ogilvie, Jennifer B., MD

    Published in The Journal of surgical research (01-07-2017)
    “…Abstract Background The incidence of well-differentiated thyroid cancer (WDTC) is increasing. Patients with higher socioeconomic status (SES) have higher rates…”
    Get full text
    Journal Article
  4. 4

    Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients by Zagzag, Jonathan, Malone, Michael K, Lopresti, Melissa A, Ogilvie, Jennifer B, Patel, Kepal N, Heller, Keith S

    Published in PloS one (04-04-2016)
    “…The incidence of well-differentiated thyroid cancer (WDTC) is increasing rapidly. Many authors feel that this increase is due to over-diagnosis and that one of…”
    Get full text
    Journal Article
  5. 5

    Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings by Nichols, Kenneth J, Tomas, Maria B, Tronco, Gene G, Rini, Josephine N, Kunjummen, Biju D, Heller, Keith S, Sznyter, Laura A, Palestro, Christopher J

    Published in Radiology (01-07-2008)
    “…To retrospectively compare the accuracy of various parathyroid scintigraphy readings for single-gland disease (SGD) and multigland disease (MGD) in patients…”
    Get more information
    Journal Article
  6. 6

    Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer by Dultz, Linda A., MD, Dhar, Shumon, BS, Ogilvie, Jennifer B., MD, Heller, Keith S., MD, Bar-Sagi, Dafna, PhD, Patel, Kepal N., MD

    Published in Surgery (01-12-2013)
    “…Background The BRAF V600E (BRAF+) mutation activates the mitogen-activated protein kinase (MAPK/ERK) pathway and may confer an aggressive phenotype in…”
    Get full text
    Journal Article
  7. 7

    Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas by Ogilvie, Jennifer B., MD, Patel, Kepal N., MD, Heller, Keith S., MD

    Published in Surgery (01-12-2010)
    “…Background The 2009 ATA Guidelines state “lobectomy alone may be sufficient treatment for small (<1 cm), low risk, unifocal, intrathyroidal papillary…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    The clinical significance and anatomic distribution of parathyroid double adenomas by Bergson, Eric J, Heller, Keith S

    “…Parathyroid double adenomas are reported to occur in 3% to 12% of cases of primary hyperparathyroidism, but the very existence of double adenomas has been…”
    Get full text
    Journal Article
  12. 12

    Re-operation for bleeding after thyroidectomy and parathyroidectomy by Abbas, Ghulam, Dubner, Sanford, Heller, Keith S.

    Published in Head & neck (01-07-2001)
    “…Background This study was undertaken to determine the frequency and timing of re‐operation for bleeding following thyroidectomy (THY) and parathyroidectomy…”
    Get full text
    Journal Article
  13. 13

    Thyroid cancers detected by imaging are not necessarily small or early stage by Malone, Michael K, Zagzag, Jonathan, Ogilvie, Jennifer B, Patel, Kepal N, Heller, Keith S

    Published in Thyroid (New York, N.Y.) (01-02-2014)
    “…The incidence of well-differentiated thyroid cancer (WDTC) in the United States is increasing rapidly. Much of this increase is due to the detection by imaging…”
    Get more information
    Journal Article
  14. 14

    Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer by Zanocco, Kyle, Kaltman, David J., Wu, James X., Fingeret, Abbey, Heller, Keith S., Lee, James A., Yeh, Michael W., Sosa, Julie Ann, Sturgeon, Cord

    Published in Annals of surgical oncology (01-04-2018)
    “…ABSTRACT Background Some surgeons perform flexible fiberoptic laryngoscopy (FFL) in all patients prior to thyroid cancer operations. Given the low likelihood…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Surgical Approach and Outcomes in Patients with Lithium-Associated Hyperparathyroidism by Marti, Jennifer L., Yang, Catherine S., Carling, Tobias, Roman, Sanziana A., Sosa, Julie A., Donovan, Patricia, Guoth, Maria S., Heller, Keith S., Udelsman, Robert

    Published in Annals of surgical oncology (01-10-2012)
    “…Background Patients receiving lithium therapy are at elevated risk of developing hyperparathyroidism. In lithium-associated hyperparathyroidism (LAH), the…”
    Get full text
    Journal Article
  17. 17

    Importance of intraoperative parathyroid hormone measurement in the diagnosis of parathyroid lipoadenoma by Lee, Ann Y., Wang, Beverly Y., Heller, Keith S., Rosenthal, Eben L.

    Published in Head & neck (01-06-2011)
    “…Background. Parathyroid lipoadenoma is an uncommon tumor that may be difficult to diagnose on intraoperative frozen section. Intraoperative parathyroid hormone…”
    Get full text
    Journal Article
  18. 18

    Persistently elevated parathyroid hormone levels after parathyroid surgery by Wang, Tracy S., Ostrower, Samuel T., Heller, Keith S.

    Published in Surgery (01-12-2005)
    “…Persistent elevation of serum parathyroid hormone (PTH), despite normocalcemia, occurs in 8% to 40% of patients after parathyroidectomy. Explanations have…”
    Get full text
    Journal Article
  19. 19

    Incidence of Metastatic Well-Differentiated Thyroid Cancer in Cervical Lymph Nodes by Wang, Tracy S, Dubner, Sanford, Sznyter, Laura A, Heller, Keith S

    “…OBJECTIVE To determine the incidence of clinically positive lateral cervical nodes at presentation and after initial treatment in patients with…”
    Get full text
    Journal Article
  20. 20

    Follicular Variant of Papillary Thyroid Cancer: Encapsulated, Nonencapsulated, and Diffuse: Distinct Biologic and Clinical Entities by Gupta, Sachin, Ajise, Oluyomi, Dultz, Linda, Wang, Beverly, Nonaka, Daisuke, Ogilvie, Jennifer, Heller, Keith S, Patel, Kepal N

    “…OBJECTIVE To examine genotypic and clinical differences between encapsulated, nonencapsulated, and diffuse follicular variant of papillary thyroid carcinoma…”
    Get full text
    Journal Article